The chart below shows what happened during the study.
Before the participants took study treatment
1 visit
The study doctors:
checked the health of the participants to took pictures of the participants’ tumors
make sure they could join the study using CT or MRI scans
did a physical exam and asked about if needed, used surgery to take a sample
the participants’ medications and any of the tumor, also known as a biopsy
medical problems
took blood and urine samples
The participants:
answered questionnaires about their
tested for BRCA1 and BRCA2 mutations
symptoms
in the participants’ ovarian cancer
Up to 4 weeks
While the participants took study treatment
Visits about every 4 weeks for the first 12 months, then visits every 12 weeks
The study doctors:
checked the participants’ physical health took blood and urine samples
every 8 weeks for the first 12 months,
then every 12 weeks
The participants:
asked about the participants’ medications took their doses of olaparib as tablets
and any medical problems by mouth twice a day at home
took pictures of the participants’ tumors
answered questionnaires about their
using CT or MRI scans every 8 weeks
symptoms and quality of life 2 times,
for the first 12 months, then every 12
and then at every study visit that their
weeks until the participants’ cancer
tumors were measured
got worse
Until the participants stopped study treatment
After the participants took their last dose of study treatment
Visits every 8 weeks for the first 12 months, then every 12 weeks
The study doctors:
checked the participants’ physical health took pictures of the participants’ tumors
and asked about their medications using CT or MRI scans
took blood and urine samples The participants:
answered questionnaires about their
symptoms and quality of life
Until the participants’ cancer got worse
4 weeks after the participants took their last dose of study treatment
1 visit
The study doctors: The participants:
asked about the participants’ answered questionnaires about their
medications and any medical problems symptoms and quality of life
took blood and urine samples
The participants were then contacted every 12 weeks until they died
6 | Clinical Study Results